Clinical characteristics of patients with early-and late-onset optic neuromyelitis optica spectrum disease.

Autor: LI Fei, LIU Ting, Yang Yi-hao, LIN Hui-xia, TONG jing-yi, LI Zong-jun, LIANG Bin-ji, LI Qi-fu
Předmět:
Zdroj: Journal of Hainan Medical University; Jan2024, Vol. 30 Issue 2, p14-19, 6p
Abstrakt: Objective: To analyze the different clinical features of patients with early-onset (EO-NMOSDs) and late-onset neuromyelitis optica spectrum diseases (LO-NMOSDs). Methods: A total of 51patients with neuromyelitis optica spectrum disease who were diagnosed in our hospital for the first time from January 2015 to December 2022 were included in the First Affiliated Hospital of Hainan Medical College and divided into 22 cases in the EO-NMOSDs group and 29 cases in the LO-NMOSDs group according to whether the age of onset was ≥ 50 years old. The basic data, Extended Disability Status Scale (EDSS) score, blood and cerebrospinal fluid test indicators of the two groups were statistically analyzed. Results: There were no significant differences in demographic characteristics, clinical features and serum AQP-4 antibody positivity rate between the two groups (all P>0.05), and there were significant differences in triglycerides (TG), low-density lipoprotein (LDL), apolipoprotein A (APOA), apolipoprotein B (APOB) and lipoprotein a (P=0.010, P=0.048, P=0.014, P=0.061, P=0.001, respectively), and cerebrospinal fluid LDH, There were significant differences between microprotein quantification and EDSS score (P=0.018, P=0.034, P=0.025, respectively), and the level of microprotein quantification in cerebrospinal fluid of LO-NMOSDs had a certain correlation with the degree of disability (r=0.52, P<0.03). Conclusion: LO-NMOSDs and EONMOSDs group patients have similar demographic characteristics, serum AQP-4 antibody positive rate and clinical features, but compared with EO-NMOSDs, patients in LO-NMOSDs group are prone to abnormal lipid metabolism, higher trace proteins in cerebrospinal fluid and more likely to be disabled, and among LO-NMOSDs, the higher the trace protein in the cerebrospinal fluid, the more severe the disability status of patients. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index